Video | Osher Lifelong Learning Institute

Video Details 
The Futurescape of Medicine: New Approaches to the Treatment of Gynecologic Cancers
The Futurescape of Medicine: New Approaches to the Treatment of Gynecologic Cancers
Claire Friedman, MD and Alison Schram, MD
Claire Friedman, MD is an Assistant Attending in the Gynecologic Medical Oncology Service at Memorial Sloan Kettering Cancer, with an additional appointment in the Phase 1 Early Drug Development service.  She is engaged in the development of new treatment paradigms for gynecologic cancers that incorporate checkpoint blockade and other immune-based strategies, as well as spearheading efforts within her service to examine mechanisms of checkpoint blockade resistance.  She also is one of the clinical leads for MSK-SPECTRUM, a multi-modal prospective study of spatio-temporal determinants of tumor evolution, treatment and response in high grade serous ovarian cancer.

Alison Schram is a medical oncologist with an expertise in early-phase clinical trials. She also cares for women with uterine (endometrial) cancer, ovarian cancer, and cervical cancer.

Her research focuses on finding and targeting the molecular changes that drive a person’s tumor. This allows us to more precisely tailor treatments to their disease. By developing and running early-phase clinical trials, she hopes to bring new and more effective therapies to people with all types of cancer.
She understands that being diagnosed with cancer is scary, and navigating treatment can be overwhelming. She help guide her patients through the process so that they feel supported and confident in their care. Together, they create a personalized treatment plan based on what is important to them. She works with my colleagues in surgery, radiation oncology, supportive care, pathology, and radiology to find the best treatment approach for each person.
Lecture Type : Other      
Lecture Date : 11/02/2021      
Program Year : 2021-22      
Term : Fall      
Fee : $10.00